Plain-English translation of NCT05042258 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether , a medication approved for severe eczema, can also help children sleep better at night. Eczema often causes intense itching that keeps children awake, disrupting their sleep and their body's natural rhythms. Researchers want to see if treating the eczema with this medication will improve both sleep quality and daytime functioning.
Many children with severe eczema struggle with sleep problems because the intense itching keeps them awake at night. While this medication works well for the skin disease itself, doctors want to understand whether treating the eczema also helps restore normal sleep patterns and improve children's overall health and well-being.
You likely qualify if…
You likely don't qualify if…
You'll visit the study site twice — once before starting treatment and once after 12 weeks. At each overnight visit, you'll stay for a sleep study where researchers measure your sleep patterns, take blood samples, and use special skin sensors to monitor your eczema. Between visits, you'll give yourself a weekly injection of the medication at home. The study involves some prep requirements like avoiding topical steroids and moisturizers before your overnight visits, and researchers will take photographs and skin samples to track changes.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States